INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 104 filers reported holding INTERSECT ENT INC in Q4 2016. The put-call ratio across all filers is 112.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $32,000 | +23.1% | 2,000 | 0.0% | 0.05% | +24.3% |
| Q2 2016 | $26,000 | -31.6% | 2,000 | 0.0% | 0.04% | -35.1% |
| Q1 2016 | $38,000 | -15.6% | 2,000 | 0.0% | 0.06% | -19.7% |
| Q4 2015 | $45,000 | -4.3% | 2,000 | 0.0% | 0.07% | -7.8% |
| Q3 2015 | $47,000 | -17.5% | 2,000 | 0.0% | 0.08% | -15.4% |
| Q2 2015 | $57,000 | +9.6% | 2,000 | 0.0% | 0.09% | +3.4% |
| Q1 2015 | $52,000 | – | 2,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |